Nutrition Research and Practice

한국영양학회 (The Korean Nutrition Society)
권호 표지
DOI QR코드

DOI QR Code

Effect of isoflavone supplementation on menopausal symptoms: a systematic review and meta-analysis of randomized controlled trials

  • Kang, Inhae (Department of Food Science and Nutrition, Jeju National University) ;
  • Rim, Chai Hong (Department of Radiation Oncology, Korea University Ansan Hospital) ;
  • Yang, Hee Sun (Division of Functional Food & Nutrition, National Institute of Agricultural Sciences, Rural Development Administration) ;
  • Choe, Jeong-Sook (Division of Functional Food & Nutrition, National Institute of Agricultural Sciences, Rural Development Administration) ;
  • Kim, Ji Yeon (Department of Food Science and Technology, Seoul National University of Science and Technology) ;
  • Lee, Myoungsook (Department of Food and Nutrition, School of Bio-Health Convergence, Sungshin Women's University)
  • 투고 : 2021.11.04
  • 심사 : 2022.04.25
  • 발행 : 2022.05.20
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

BACKGROUND/OBJECTIVES: Complementary and alternative medicines can be used to alleviate climacteric symptoms that significantly affect the quality of life of postmenopausal women. Isoflavones are the most common plant-based therapies for postmenopausal changes, but the results of previous studies have been controversial. MATERIALS/METHODS: To investigate whether isoflavones would affect menopausal symptoms as well as ovarian hormones, we performed a systematic review and meta-analysis. The PubMed and EMBASE databases were used to perform the systematic search. Included studies were limited to randomized controlled trials (RCTs) assessing the impact of isoflavone supplementation on menopausal symptoms. RESULTS: Eleven studies were included for the final quantitative assessment. Isoflavone intervention was varied between 49.3 and 135 mg of isoflavones per day for 12 wk-2 yrs. The meta-analysis showed that supplementation of isoflavones significantly increased the estradiol levels (standardized mean difference [SMD] = 0.615, P = 0.035) and Kupperman index (SMD = 3.121, P = 0.003) but had no significant effect on hot flashes, follicle-stimulating hormone, and luteinizing hormone. However, both estradiol and the Kupperman index showed significant heterogeneity among studies (I2 = 94.7%, P < 0.001 and I2 = 98.1%, P < 0.001, respectively). CONCLUSIONS: Although the results showed a significant SMD in estradiol and the Kupperman index, the results should be interpreted with caution due to the high heterogeneity. Further validation with a larger RCT will be necessary. Overall, isoflavone supplementation has distinct effects on the climacteric symptoms and hormonal changes in postmenopausal women.

키워드

과제정보

This study is a part of the "phytonutrients" subcommittee for KDRIs.

참고문헌

  1. Burger HG, Dudley EC, Robertson DM, Dennerstein L. Hormonal changes in the menopause transition. Recent Prog Horm Res 2002;57:257-75. https://doi.org/10.1210/rp.57.1.257
  2. Barnabei VM, Grady D, Stovall DW, Cauley JA, Lin F, Stuenkel CA, Stefanick ML, Pickar JH. Menopausal symptoms in older women and the effects of treatment with hormone therapy. Obstet Gynecol 2002;100:1209-18. https://doi.org/10.1016/S0029-7844(02)02369-4
  3. Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W, Knopp R, Lowery M, Satterfield S, Schrott H, et al. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002;288:58-66. https://doi.org/10.1001/jama.288.1.58
  4. Nachtigall LE, Nachtigall RH, Nachtigall RD, Beckman EM. Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. Obstet Gynecol 1979;54:74-9. https://doi.org/10.1097/00006250-197907000-00017
  5. Cos P, De Bruyne T, Apers S, Vanden Berghe D, Pieters L, Vlietinck AJ. Phytoestrogens: recent developments. Planta Med 2003;69:589-99. https://doi.org/10.1055/s-2003-41122
  6. Moutsatsou P. The spectrum of phytoestrogens in nature: our knowledge is expanding. Hormones (Athens) 2007;6:173-93.
  7. Pilsakova L, Riecansky I, Jagla F. The physiological actions of isoflavone phytoestrogens. Physiol Res 2010;59:651-64. https://doi.org/10.33549/physiolres.931902
  8. Ewies AA. Phytoestrogens in the management of the menopause: up-to-date. Obstet Gynecol Surv 2002;57:306-13. https://doi.org/10.1097/00006254-200205000-00023
  9. Franco OH, Chowdhury R, Troup J, Voortman T, Kunutsor S, Kavousi M, Oliver-Williams C, Muka T. Use of plant-based therapies and menopausal symptoms: a systematic review and meta-analysis. JAMA 2016;315:2554-63. https://doi.org/10.1001/jama.2016.8012
  10. Chen MN, Lin CC, Liu CF. Efficacy of phytoestrogens for menopausal symptoms: a meta-analysis and systematic review. Climacteric 2015;18:260-9. https://doi.org/10.3109/13697137.2014.966241
  11. Higgins JP, Savovic J, Page MJ, Elbers RG, Sterne JA. Assessing risk of bias in a randomized trial. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions. London: The Cochrane Collaboration; 2019. p.205-28.
  12. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58. https://doi.org/10.1002/sim.1186
  13. Cochran WG. The combination of estimates from different experiments. Biometrics 1954;10:101-29. https://doi.org/10.2307/3001666
  14. Page MJ, Higgins JP, Sterne JA. Assessing risk of bias due to missing results in a synthesis. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions. London: The Cochrane Collaboration; 2019. p.349-74.
  15. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34. https://doi.org/10.1136/bmj.315.7109.629
  16. Harrer M, Cuijpers P, Furukawa TA, Ebert DD. Ch 5.4. Outlier & influential cases. In: Harrer M, Cuijpers P, Furukawa TA, Ebert DD, editors. Doing Meta-Analysis with R: a Hands-on Guide. London: Chapman and Hall/CRC; 2021. p.153.
  17. Han KK, Soares JM Jr, Haidar MA, de Lima GR, Baracat EC. Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstet Gynecol 2002;99:389-94. https://doi.org/10.1016/S0029-7844(01)01744-6
  18. Steinberg FM, Murray MJ, Lewis RD, Cramer MA, Amato P, Young RL, Barnes S, Konzelmann KL, Fischer JG, Ellis KJ, et al. Clinical outcomes of a 2-y soy isoflavone supplementation in menopausal women. Am J Clin Nutr 2011;93:356-67. https://doi.org/10.3945/ajcn.110.008359
  19. Maskarinec G, Franke AA, Williams AE, Hebshi S, Oshiro C, Murphy S, Stanczyk FZ. Effects of a 2-year randomized soy intervention on sex hormone levels in premenopausal women. Cancer Epidemiol Biomarkers Prev 2004;13:1736-44. https://doi.org/10.1158/1055-9965.1736.13.11
  20. Lee H, Choue R, Lim H. Effect of soy isoflavones supplement on climacteric symptoms, bone biomarkers, and quality of life in Korean postmenopausal women: a randomized clinical trial. Nutr Res Pract 2017;11:223-31. https://doi.org/10.4162/nrp.2017.11.3.223
  21. Sapbamrer R, Visavarungroj N, Suttajit M. Effects of dietary traditional fermented soybean on reproductive hormones, lipids, and glucose among postmenopausal women in northern Thailand. Asia Pac J Clin Nutr 2013;22:222-8.
  22. Jou HJ, Wu SC, Chang FW, Ling PY, Chu KS, Wu WH. Effect of intestinal production of equol on menopausal symptoms in women treated with soy isoflavones. Int J Gynaecol Obstet 2008;102:44-9. https://doi.org/10.1016/j.ijgo.2008.01.028
  23. Radhakrishnan G, Rashmi NA, Vaid NB. Evaluation of isoflavone rich soy protein supplementation for postmenopausal therapy. Pak J Nutr 2009;8:1009-17. https://doi.org/10.3923/pjn.2009.1009.1017
  24. St Germain A, Peterson CT, Robinson JG, Alekel DL. Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment. Menopause 2001;8:17-26. https://doi.org/10.1097/00042192-200101000-00005
  25. Liu ZM, Chen YM, Ho SC, Ho YP, Woo J. Effects of soy protein and isoflavones on glycemic control and insulin sensitivity: a 6-mo double-blind, randomized, placebo-controlled trial in postmenopausal Chinese women with prediabetes or untreated early diabetes. Am J Clin Nutr 2010;91:1394-401. https://doi.org/10.3945/ajcn.2009.28813
  26. Llaneza P, Gonzalez C, Fernandez-Inarrea J, Alonso A, Diaz F, Perez-Lopez FR. Soy isoflavones improve insulin sensitivity without changing serum leptin among postmenopausal women. Climacteric 2012;15:611-20. https://doi.org/10.3109/13697137.2011.631062
  27. Cheng G, Wilczek B, Warner M, Gustafsson JA, Landgren BM. Isoflavone treatment for acute menopausal symptoms. Menopause 2007;14:468-73. https://doi.org/10.1097/GME.0b013e31802cc7d0
  28. Liu ZM, Ho SC, Woo J, Chen YM, Wong C. Randomized controlled trial of whole soy and isoflavone daidzein on menopausal symptoms in equol-producing Chinese postmenopausal women. Menopause 2014;21:653-60. https://doi.org/10.1097/GME.0000000000000102
  29. Lambert MN, Thorup AC, Hansen ES, Jeppesen PB. Combined red clover isoflavones and probiotics potently reduce menopausal vasomotor symptoms. PLoS One 2017;12:e0176590. https://doi.org/10.1371/journal.pone.0176590
  30. Hooper L, Ryder JJ, Kurzer MS, Lampe JW, Messina MJ, Phipps WR, Cassidy A. Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis. Hum Reprod Update 2009;15:423-40. https://doi.org/10.1093/humupd/dmp010
  31. Fritz H, Seely D, Flower G, Skidmore B, Fernandes R, Vadeboncoeur S, Kennedy D, Cooley K, Wong R, Sagar S, et al. Soy, red clover, and isoflavones and breast cancer: a systematic review. PLoS One 2013;8:e81968. https://doi.org/10.1371/journal.pone.0081968
  32. Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med 2002;137:805-13. https://doi.org/10.7326/0003-4819-137-10-200211190-00009
  33. Haines CJ, Xing SM, Park KH, Holinka CF, Ausmanas MK. Prevalence of menopausal symptoms in different ethnic groups of Asian women and responsiveness to therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study. Maturitas 2005;52:264-76. https://doi.org/10.1016/j.maturitas.2005.03.012
  34. Shea JL. Parsing the ageing Asian woman: symptom results from the China study of midlife women. Maturitas 2006;55:36-50. https://doi.org/10.1016/j.maturitas.2005.12.010
  35. Clarkson TB, Utian WH, Barnes S, Gold EB, Basaria SS, Aso T, Kronenberg F, Frankenfeld CL, Cline JM, Landgren BM, et al. The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010). Menopause 2011;18:732-53. https://doi.org/10.1097/gme.0b013e31821fc8e0
  36. Li N, Wu X, Zhuang W, Xia L, Chen Y, Zhao R, Yi M, Wan Q, Du L, Zhou Y. Soy and isoflavone consumption and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomized trials in humans. Mol Nutr Food Res 2020;64:e1900751.
  37. Thomas AJ, Ismail R, Taylor-Swanson L, Cray L, Schnall JG, Mitchell ES, Woods NF. Effects of isoflavones and amino acid therapies for hot flashes and co-occurring symptoms during the menopausal transition and early postmenopause: a systematic review. Maturitas 2014;78:263-76. https://doi.org/10.1016/j.maturitas.2014.05.007
  38. Chen LR, Ko NY, Chen KH. Isoflavone supplements for menopausal women: a systematic review. Nutrients 2019;11:E2649.
  39. Daily JW, Ko BS, Ryuk J, Liu M, Zhang W, Park S. Equol decreases hot flashes in postmenopausal women: a systematic review and meta-analysis of randomized clinical trials. J Med Food 2019;22:127-39. https://doi.org/10.1089/jmf.2018.4265
  40. Ghazanfarpour M, Latifnejad Roudsari R, Treglia G, Sadeghi R. Topical administration of isoflavones for treatment of vaginal symptoms in postmenopausal women: a systematic review of randomised controlled trials. J Obstet Gynaecol 2015;35:783-7. https://doi.org/10.3109/01443615.2015.1011104
  41. Brink E, Coxam V, Robins S, Wahala K, Cassidy A, Branca F; PHYTOS Investigators. Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study. Am J Clin Nutr 2008;87:761-70. https://doi.org/10.1093/ajcn/87.3.761
  42. Ryan-Borchers TA, Park JS, Chew BP, McGuire MK, Fournier LR, Beerman KA. Soy isoflavones modulate immune function in healthy postmenopausal women. Am J Clin Nutr 2006;83:1118-25. https://doi.org/10.1093/ajcn/83.5.1118
  43. Tai TY, Tsai KS, Tu ST, Wu JS, Chang CI, Chen CL, Shaw NS, Peng HY, Wang SY, Wu CH. The effect of soy isoflavone on bone mineral density in postmenopausal Taiwanese women with bone loss: a 2-year randomized double-blind placebo-controlled study. Osteoporos Int 2012;23:1571-80. https://doi.org/10.1007/s00198-011-1750-7
  44. Charles C, Yuskavage J, Carlson O, John M, Tagalicud AS, Maggio M, Muller DC, Egan J, Basaria S. Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women. Menopause 2009;16:395-400. https://doi.org/10.1097/gme.0b013e3181857979
  45. Chilibeck PD, Vatanparast H, Pierson R, Case A, Olatunbosun O, Whiting SJ, Beck TJ, Pahwa P, Biem HJ. Effect of exercise training combined with isoflavone supplementation on bone and lipids in postmenopausal women: a randomized clinical trial. J Bone Miner Res 2013;28:780-93. https://doi.org/10.1002/jbmr.1815
  46. Basaria S, Wisniewski A, Dupree K, Bruno T, Song MY, Yao F, Ojumu A, John M, Dobs AS. Effect of high-dose isoflavones on cognition, quality of life, androgens, and lipoprotein in post-menopausal women. J Endocrinol Invest 2009;32:150-5. https://doi.org/10.1007/BF03345705
  47. Levis S, Strickman-Stein N, Ganjei-Azar P, Xu P, Doerge DR, Krischer J. Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms: a randomized, double-blind trial. Arch Intern Med 2011;171:1363-9. https://doi.org/10.1001/archinternmed.2011.330
  48. Valentine JC, Pigott TD, Rothstein HR. How many studies do you need? A primer on statistical power for meta-analysis (vol 35, pg 215, 2010). J Educ Behav Stat 2010;35:375. https://doi.org/10.3102/1076998610376621
  49. Weare K, Nind M. Mental health promotion and problem prevention in schools: what does the evidence say? Health Promot Int 2011;26 Suppl 1:i29-69.